{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:10:08Z","timestamp":1768965008195,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clbc.2025.07.011","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:21:44Z","timestamp":1752607304000},"page":"195-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Residual Axillary Lymph Node Metastases After Neoadjuvant Treatment in Breast Cancer"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3817-6898","authenticated-orcid":false,"given":"Rodrigo","family":"Vaz Reis","sequence":"first","affiliation":[]},{"given":"Paula","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"B\u00e1rbara","family":"Peleteiro","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Lu\u00eds Fougo","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clbc.2025.07.011_bib0001","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(21)00589-1","article-title":"Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2025.07.011_bib0002","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jnci\/dji021","article-title":"Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis","volume":"97","author":"Mauri","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2025.07.011_bib0003","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","article-title":"Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from national surgical adjuvant breast and bowel project B-18","volume":"15","author":"Fisher","year":"1997","journal-title":"JCO"},{"issue":"10","key":"10.1016\/j.clbc.2025.07.011_bib0004","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.6004\/jnccn.2017.0158","article-title":"Pathologic complete response after neoadjuvant chemotherapy and long-term outcomes among young women with breast cancer","volume":"15","author":"Spring","year":"2017","journal-title":"JNCCN J Natl Comprehen Ca Netw"},{"issue":"9938","key":"10.1016\/j.clbc.2025.07.011_bib0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.clbc.2025.07.011_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071565","article-title":"Surgical management of the axilla in clinically node-positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: current status, knowledge gaps, and rationale for the eubreast-03 axsana study","volume":"13","author":"Banys-paluchowski","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.clbc.2025.07.011_bib0007","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2025.07.011_bib0008","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients","volume":"250","author":"Hunt","year":"2009","journal-title":"Ann Surg"},{"issue":"14","key":"10.1016\/j.clbc.2025.07.011_bib0009","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.clbc.2025.07.011_bib0010","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2025.07.011_bib0011","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2025.07.011_bib0012","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1245\/s10434-018-6429-2","article-title":"Is low-volume disease in the sentinel node after neoadjuvant chemotherapy an indication for axillary dissection?","volume":"25","author":"Moo","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"33","key":"10.1016\/j.clbc.2025.07.011_bib0013","doi-asserted-by":"crossref","first-page":"13820","DOI":"10.1073\/pnas.0905718106","article-title":"Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features","volume":"106","author":"Creighton","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clbc.2025.07.011_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101965","article-title":"HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: a systematic review and meta-analysis","volume":"84","author":"Schettini","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"10.1016\/j.clbc.2025.07.011_bib0015","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/annonc\/mdy127","article-title":"Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis","volume":"29","author":"Poggio","year":"2018","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2025.07.011_bib0016","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-008-0128-9","article-title":"Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients","volume":"115","author":"Byrski","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2025.07.011_bib0017","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: american Society of Clinical Oncology\/College of American Pathologists Clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2025.07.011_bib0018","series-title":"American Joint Committee on Cancer. AJCC cancer staging manual","article-title":"Breast","author":"Hortobagyi","year":"2017"},{"issue":"5","key":"10.1016\/j.clbc.2025.07.011_bib0019","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clbc.2020.04.008","article-title":"Patterns of failure in women who have residual nodal disease after neoadjuvant chemotherapy for breast cancer according to extent of lymph node surgery","volume":"20","author":"Kozak","year":"2020","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2025.07.011_bib0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejso.2022.11.099","article-title":"Omission of axillary lymph node dissection in patients with ypN+ breast cancer after neoadjuvant chemotherapy: a retrospective multicenter study (KROG 21-06)","volume":"49","author":"Park","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2025.07.011_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-88442-x","article-title":"Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy","volume":"11","author":"Chun","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.clbc.2025.07.011_bib0022","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jss.2023.08.004","article-title":"Omission of axillary dissection in node positive breast cancer after neoadjuvant systemic therapy","volume":"292","author":"Peery","year":"2023","journal-title":"J Surg Res"},{"issue":"4","key":"10.1016\/j.clbc.2025.07.011_bib0023","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/SLA.0000000000004356","article-title":"Diagnostic performance of noninvasive imaging for assessment of axillary response after neoadjuvant systemic therapy in clinically node-positive breast cancer: a systematic review and meta-analysis","volume":"273","author":"Samiei","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2025.07.011_bib0024","article-title":"Axillary surgery in breast cancer - primary results of the INSEMA trial","volume":"12","author":"Reimer","year":"2024","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.clbc.2025.07.011_bib0025","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","article-title":"Sentinel lymph node biopsy vs No axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial","volume":"9","author":"Gentilini","year":"2023","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2025.07.011_bib0026","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1148\/radiol.2019190014","article-title":"Predicting axillary response to neoadjuvant chemotherapy: breast MRI and US in patients with node-positive breast cancer","volume":"293","author":"Kim","year":"2019","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.clbc.2025.07.011_bib0027","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1245\/s10434-018-6345-5","article-title":"A predictive model for axillary node pathologic complete response after neoadjuvant chemotherapy for breast cancer","volume":"25","author":"Kantor","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2025.07.011_bib0028","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00595-019-01858-x","article-title":"Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy","volume":"50","author":"Iwamoto","year":"2020","journal-title":"Surg Today"},{"issue":"5","key":"10.1016\/j.clbc.2025.07.011_bib0029","doi-asserted-by":"crossref","first-page":"E553","DOI":"10.1097\/SLA.0000000000004572","article-title":"A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients","volume":"276","author":"Kuemmel","year":"2022","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.clbc.2025.07.011_bib0030","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jamasurg.2022.3907","article-title":"Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer","volume":"157","author":"Simons","year":"2022","journal-title":"JAMA Surg"},{"issue":"0","key":"10.1016\/j.clbc.2025.07.011_bib0031","article-title":"Sentinel lymph node biopsy or targeted axillary dissection in node positive breast cancer patients submitted to neoadjuvant therapy?","volume":"0","author":"Sousa","year":"2025","journal-title":"Portug J Surg"},{"issue":"6","key":"10.1016\/j.clbc.2025.07.011_bib0032","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.clbc.2025.07.011_bib0033","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/SLA.0000000000005633","article-title":"Sentinel lymph node mapping in breast cancer patients through fluorescent imaging using indocyanine green the influence trial","volume":"276","author":"Bargon","year":"2022","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.clbc.2025.07.011_bib0034","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-022-06545-z","article-title":"Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol","volume":"193","author":"van Loevezijn","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.clbc.2025.07.011_bib0035","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamasurg.2023.1772","article-title":"Safety of targeted axillary dissection after neoadjuvant therapy in patients with node-positive breast cancer","volume":"158","author":"Kuemmel","year":"2023","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.clbc.2025.07.011_bib0036","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10549-019-05290-0","article-title":"Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice","volume":"177","author":"Saw","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.clbc.2025.07.011_bib0037","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the \u201cseed and soil\u201d hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat Rev Ca"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925002071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925002071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:57:57Z","timestamp":1768921077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820925002071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1526820925002071"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2025.07.011","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Residual Axillary Lymph Node Metastases After Neoadjuvant Treatment in Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2025.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}